Vaxonella

Source SynBio Database
Organization Prokarium
Website URL www.prokarium.com/#technology-section
Market status On the market + Under Development
Industry Health
Value chain stage Finished Product
Intended consumer Commercial
Production process Closed Production
Business models B2C
Product categories Medical Treatment
Biotech components Bacteria
Organization type(s) Private Company
Funding types Venture Capital
Known funding amount $12,600,000 USD
Country of production UK
Notes Acquired from Emergent Biosolutions in 2012 The vaccine uses an attenuated strain of Salmonella enterica that is genetically engineered to express antigens from the Salmonella Typhi strain, ZH9.
Additional link #1 labiotech.eu/medical/oral-vaccines-typhoid-…
Added 6 years ago
Last modified 5 years ago